Eyewear Manufacturer Shares Vision for Breast Cancer Cure
On this final day of NSC’s 2009 Expo, exhibitor Wiley X®, a maker of protective eyewear (booth 610), said it is looking forward to 2010. For all of next year, the manufacturer has pledged to donate $2.50 from the sale of every non-polarized pair of its Lacey sunglasses and $3.50 from every polarized pair of the line to The Breast Cancer Research Foundation (BCRF).
This official partnership will start Jan. 1, 2010, and will be supported throughout Wiley X’s U.S. dealer network. Each pair of Wiley X Lacey sunglasses will sport a signature BCRF Pink Ribbon cling sticker on the lens to raise awareness of the organization’s efforts to find a cure. The company said this particular line of its sunglasses are a perfect vehicle for this important message because it sports coral pink lenses and a distinct, pink cotton-candy colored frame, which melds seamlessly with the recognized hue affiliated with breast cancer awareness.
For its part, the not-for-profit BCRF said it is dedicated to directing at least 85 cents of every dollar raised directly to research to prevent breast cancer and find a cure for it in our lifetime. This month, nearly $29 million will be awarded to 171 scientists across the United States, Canada, Latin America, Europe, the Middle East, and Australia, the organization said, adding that for the eighth consecutive year, it has received Charity Navigator’s highest rating, four stars, as well as the American Institute of Philanthropy’s highest possible rating, an A+.
“We’re fortunate that our Laceys have gained such widespread popularity, and we are honored to have the chance to partner with such a successful, well-respected organization like BCRF in this fight for a cure,” said Wiley X President of Sales Myles Freeman. “This is a chance for us to do our part in raising money and awareness, and this worthy cause deserves our attention and our efforts to make a difference.”
For more information about Wiley X eyewear or the company’s partnership with BCRF, visit www.wileyx.com. For information about BCRF’s clinical and translational research and other activities, go to www.bcrfcure.org.